Literature DB >> 10591185

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

T L Chapman1, A P Heikeman, P J Bjorkman.   

Abstract

LIR-1 is a class I MHC receptor related to natural killer inhibitory receptors (KIRs). Binding of LIR-1 or KIRs to class I molecules results in inhibitory signals. Unlike individual KIRs, LIR-1 recognizes many class I alleles and also binds UL18, a human cytomegalovirus class I MHC homolog. Here, we show that LIR-1 interacts with the relatively nonpolymorphic alpha3 domain of class I proteins and the analogous region of UL18 using its N-terminal immunoglobulin-like domain. The >1000-fold higher affinity of LIR-1 for UL18 than for class I illustrates how a viral protein competes with host proteins to subvert the host immune response. LIR-1 recognition of class I molecules resembles the CD4-class II MHC interaction more than the KIR-class I interaction, implying a functional distinction between LIR-1 and KIRs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591185     DOI: 10.1016/s1074-7613(00)80135-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  106 in total

1.  An N-terminal domain of herpes simplex virus type Ig E is capable of forming stable complexes with gI.

Authors:  S M Rizvi; M Raghavan
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.

Authors:  Mildred Foster-Cuevas; Gavin J Wright; Michael J Puklavec; Marion H Brown; A Neil Barclay
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Michelle Pitt; Julie Curtsinger; Xianghua Luo; Sandra Lopez-Vergès; Lewis L Lanier; Daniel Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

4.  Finding Balance: T cell Regulatory Receptor Expression during Aging.

Authors:  Mary M Cavanagh; Qian Qi; Cornelia M Weyand; Jörg J Goronzy
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

Review 5.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 6.  Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors.

Authors:  Michal Pyzik; Eve-Marie Gendron-Pontbriand; Nassima Fodil-Cornu; Silvia M Vidal
Journal:  Mamm Genome       Date:  2010-09-30       Impact factor: 2.957

7.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

8.  Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.

Authors:  Craig S Clements; Lars Kjer-Nielsen; Lyudmila Kostenko; Hilary L Hoare; Michelle A Dunstone; Eric Moses; Katy Freed; Andrew G Brooks; Jamie Rossjohn; James McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-17       Impact factor: 11.205

Review 9.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

10.  The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.

Authors:  Frédéric G Sala; Pierre-Marie Del Moral; Nathalie Pizzato; Florence Legrand-Abravanel; Philippe Le Bouteiller; Françoise Lenfant
Journal:  Immunogenetics       Date:  2004-11-13       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.